Luc Mouthon Selected Research

Churg-Strauss Syndrome (Allergic Angiitis)

1/2021	Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
12/2019	Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
11/2017	Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
3/2016	Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients.
1/2016	Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
9/2014	Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.
5/2014	Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
8/2013	Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
1/2013	Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
3/2008	[Causes and mechanisms of systemic vasculitides].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luc Mouthon Research Topics

Disease

51	Vasculitis (Vasculitides) 01/2022 - 11/2003
49	Systemic Scleroderma (Systemic Sclerosis) 04/2022 - 05/2002
28	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2022 - 11/2003
23	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2022 - 08/2007
23	Microscopic Polyangiitis 01/2022 - 02/2003
21	Infections 01/2022 - 12/2002
18	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 01/2002
17	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 11/2003
15	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 12/2003
13	Inflammation (Inflammations) 01/2022 - 11/2005
12	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2022 - 02/2003
10	Giant Cell Arteritis (Horton Disease) 03/2021 - 10/2008
10	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2021 - 12/2006
10	Systemic Vasculitis 12/2020 - 03/2005
8	Pulmonary Arterial Hypertension 10/2020 - 05/2008
7	Fibrosis (Cirrhosis) 04/2022 - 05/2007
7	COVID-19 01/2022 - 01/2020
7	Asthma (Bronchial Asthma) 01/2021 - 10/2004
6	Diffuse Scleroderma (Progressive Systemic Sclerosis) 04/2022 - 06/2004
6	Neoplasms (Cancer) 06/2021 - 04/2004
6	Connective Tissue Diseases (Connective Tissue Disease) 09/2018 - 06/2005
6	Renal Insufficiency (Renal Failure) 04/2013 - 05/2006
6	Rheumatoid Arthritis 01/2013 - 02/2007
5	Glomerulonephritis 10/2022 - 05/2007
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 11/2005
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 09/2007
5	Thrombosis (Thrombus) 01/2018 - 01/2005
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018 - 01/2005
5	Necrosis 04/2014 - 11/2005
4	Arthralgia (Joint Pain) 01/2022 - 12/2007
4	Cardiomyopathies (Cardiomyopathy) 01/2022 - 02/2013
4	Ischemia 09/2021 - 04/2006
4	Hemorrhage 01/2021 - 02/2014
4	digital ulcers 10/2020 - 04/2006
4	Mononeuropathies (Mononeuritis Multiplex) 10/2020 - 02/2014
4	Arthritis (Polyarthritis) 01/2019 - 12/2006
4	Lymphopenia (Lymphocytopenia) 05/2017 - 05/2006
4	Thrombotic Microangiopathies 12/2016 - 01/2011
4	Familial Primary Pulmonary Hypertension 06/2012 - 06/2002
3	Hepatitis B 12/2020 - 03/2008
3	Paraproteinemias (Monoclonal Gammopathy) 09/2020 - 08/2002
3	IgA Vasculitis (Purpura, Schoenlein Henoch) 09/2020 - 03/2008
3	Body Weight (Weight, Body) 04/2020 - 12/2008
3	Muscular Diseases (Myopathy) 01/2020 - 05/2006
3	Rare Diseases (Rare Disease) 01/2020 - 12/2006
3	Ulcer 09/2018 - 02/2008
3	Fever (Fevers) 07/2017 - 11/2005
3	Human Influenza (Influenza) 01/2017 - 09/2009
3	Pure Red-Cell Aplasia 02/2015 - 06/2005
3	Vascular Remodeling 11/2014 - 06/2009
3	Eosinophilia 02/2014 - 10/2004
3	Opportunistic Infections (Opportunistic Infection) 09/2010 - 02/2009
3	Virus Diseases (Viral Diseases) 03/2008 - 02/2003
2	Neonatal Systemic lupus erythematosus 10/2022 - 12/2015
2	Uveitis 08/2022 - 04/2020

Drug/Important Bio-Agent (IBA)

50	AntibodiesIBA 10/2022 - 08/2002
40	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 10/2004
23	Rituximab (Mabthera)FDA Link 10/2022 - 05/2006
20	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 02/2003
19	AutoantibodiesIBA 04/2022 - 01/2002
16	Immunosuppressive Agents (Immunosuppressants)IBA 08/2022 - 06/2005
16	Immunoglobulin G (IgG)IBA 01/2018 - 01/2002
15	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2002
15	AntigensIBA 02/2017 - 11/2003
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016 - 06/2002
13	GlucocorticoidsIBA 10/2022 - 02/2003
10	Myeloblastin (Proteinase 3)IBA 01/2019 - 05/2007
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2007
8	Biological ProductsIBA 10/2020 - 10/2004
7	ametantrone (HAQ)IBA 01/2019 - 02/2007
7	Azathioprine (Imuran)FDA LinkGeneric 01/2018 - 06/2008
7	CytokinesIBA 02/2013 - 01/2002
6	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2004
5	Complement System Proteins (Complement)IBA 01/2022 - 01/2002
4	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2008
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2006
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2016
4	CreatinineIBA 01/2020 - 05/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2004
4	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2002
4	SteroidsIBA 01/2018 - 12/2007
4	VaccinesIBA 01/2012 - 09/2009
4	Immunoglobulin M (IgM)IBA 01/2012 - 11/2003
4	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2008 - 06/2002
4	CollagenIBA 12/2006 - 05/2002
3	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2010
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 08/2013
3	RNA Polymerase IIIIBA 09/2017 - 08/2007
3	anti-endothelial cell antibodyIBA 02/2017 - 10/2008
3	Prednisone (Sone)FDA LinkGeneric 01/2016 - 10/2004
3	Monoclonal AntibodiesIBA 01/2016 - 02/2007
3	AutoantigensIBA 09/2012 - 08/2007
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2006 - 06/2002
2	Interferon Type IIBA 01/2022 - 01/2020

Therapy/Procedure

43	Therapeutics 10/2022 - 06/2002
6	Plasma Exchange 10/2022 - 05/2006
4	Remission Induction 01/2020 - 05/2014
4	Transplantation 10/2014 - 01/2003
3	Surgical Amputation (Amputations) 10/2020 - 04/2014
3	Physical Therapy Modalities (Physical Therapy Technique) 01/2019 - 12/2013